Financials data is unavailable for this security.
View more
Year on year Transgene SA had revenues fall -23.68% from 10.00m to 7.63m, though the company grew net income from a loss of 32.80m to a smaller loss of 22.33m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in EURView more
In 2023, Transgene SA increased its cash reserves by 255.80%, or 11.26m. Cash Flow from Investing totalled 34.57m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 34.67m for operations while cash generated from financing totalled 11.37m.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in EURView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
